IP Library Granted Patent US 10,208,298
Granted Patent B2
US 10,208,298 · App. 15/523,741 · Granted Feb 19, 2019

Peptide-mediated delivery of RNA-guided endonuclease into cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,208,298
App. No.
15/523,741
Granted
Feb 19, 2019
Kind
B2
Abstract

A composition is disclosed that comprises at least one protein component of an RNA-guided endonuclease (RGEN) and at least one cell-penetrating peptide (CPP), wherein the RGEN protein component and CPP are covalently or non-covalently linked to each other in an RGEN protein-CPP complex. The RGEN protein-CPP complex can traverse (i) a cell membrane, or (ii) a cell wall and cell membrane, of a cell. The RGEN protein component of an RGEN protein-CPP complex in certain embodiments can be associated with a suitable RNA component to provide an RGEN capable of specific DNA targeting. Further disclosed are compositions comprising at least one protein component of a guide polynucleotide/Cas endonuclease complex and at least one CPP, as well as methods of delivering RGEN proteins into microbial cells, as well as methods of targeting DNA with RGENs.

Claims (10)

1. A method of delivering a protein component of an RNA-guided endonuclease (RGEN) into a microbial cell, said method comprising:

contacting the microbial cell with a composition comprising the protein component of the RNA-guided endonuclease (RGEN) and at least one cell-penetrating peptide (CPP),

wherein said protein component and CPP are covalently, or non-covalently, linked to each other in an RGEN protein-CPP complex,

wherein said RGEN protein-CPP complex traverses (i) a cell membrane, or (ii) a cell wall and cell membrane, of the cell, thereby entering the microbial cell.

2. The method of claim 1 , wherein:

(i) the composition further comprises at least one RNA component that is associated with the protein component of the RGEN; or

(ii) the microbial cell comprises the RNA component, wherein the RNA component associates with the protein component of the RGEN after the RGEN protein-CPP complex enters the microbial cell;

wherein the RNA component comprises a sequence complementary to a target site sequence on a chromosome or episome in the cell, wherein the RGEN can bind to the target site sequence, and optionally cleave one or both DNA strands at the target site sequence.

3. The method of claim 2 , wherein the RGEN can cleave one or both DNA strands at the target site sequence.

4. The method of claim 3 , wherein the microbial cell further comprises a donor polynucleotide comprising at least one sequence homologous to a sequence at or near the target site sequence, and wherein the donor polynucleotide integrates at or near the target site sequence by homologous recombination.

Assignments (4)
CHANGE OF NAME Recorded May 2, 2023
From: DUPONT US HOLDING, LLC
To: IFF US HOLDING, LLC
Reel/Frame 063515/0940 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: FRISCH, RYAN L; FAN, XIAOCHUN; HONG, SEUNG-PYO; JACKSON, ETHEL NOLAND
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 045447/0681 →